Sentinel node biopsy in breast cancer patients by means of indocyanin green

Conditions

C50.9

Petronilla Staubach, Anton Scharl, Atanas Ignatov, Olaf Ortmann, Elisabeth C. Inwald et al. (10 authors)

Journal of Cancer Research and Clinical Oncology2020-11-2312 citations

Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera

Thomas Papathemelis, Evi Jablonski, Anton Scharl, Tanja Hauzenberger, Michael Gerken et al. (8 authors)

BioMed Research International2018-01-0156 citations

10.1155/2018/6251468

Interventions

Group 1: Medical record review of patients included in the study. Comparison of the overall number of sentinel nodes and the rate of positive nodes identified by indocyanin green and Technetium 99m co

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Breast cancer patients, that were treated according to the procedure mentioned above at the Klinikum St. Marien Amberg between June 2016 and Mai 2017. Patients' consent for data analysis

Exclusion criteria

Exclusion criteria: No consent

Design outcomes

Primary

Measure	Time frame
Identification of additional sentinel lymphnodes by indocyanin greeen	—

Secondary

Measure	Time frame
Identification of the sentinel lymph nodes by indocyanin green that where identified by standard procedure Evaluation of nodes detected by standard byut not by ICG detection rate by ICG false-negative-rate by ICG	—

Countries

Germany

Contacts

Public ContactThomas Papathemelis

Klinik für Frauenheilkunde und Geburtshilfe

papathemelis@web.de+49 9621 38-1371

Outcome results

None listed